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Abstract
Protein phosphatase 2A (PP2A) activity may be differentially regulated by the expression of proteins containing a related
amino acid sequence motif such as the casein kinase 2K (CK2K) subunit or SV40 small t antigen (SVt). Expression of CK2K
increases PP2A activity whereas SVt decreases its activity. In this work we have tested for the effect of the expression of a
third protein containing a similar motif that could be involved in PP2A regulation, the catalytic casein kinase 2KP subunit.
Our results show that despite the structural similarity of this protein with the other CK2 catalytic (K) subunit, the function of
the two subunits with respect to the modulation of PP2A activity is quite different : CK2K increases whereas CK2KP slightly
decreases PP2A activity. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Protein phosphatase 2A (PP2A) is a serine/threo-
nine phosphatase present in most tissues and cell
types. The holoenzyme is composed of three sub-
units: A (61 kDa), B (55 kDa) and C (37 kDa).
Subunit C is the catalytic subunit that can form the
core enzyme when it binds to subunit A [1]. The third
subunit, B, comprises several polypeptides that reg-
ulate the activity and substrate preference of the AC
complex [2].
It has been indicated that some of the B subunits
may exchange with two other proteins that could
also bind and control the activity of the AC complex.
These two proteins, SV40 small t antigen [3] and
casein kinase 2K subunit [4] have opposite e¡ects
on PP2A regulation. The binding of small t antigen
to the core enzyme results in a decrease in its phos-
phatase activity [3] whereas binding of casein kinase
2K subunit to the AC complex increases phosphatase
activity [4].
The action of small t antigen on PP2A activity
appears to be due to the interaction of a region com-
prising residues 121^131 in small t antigen with the
core enzyme [5]. This region of small t antigen is
similar to that of residues 165^175 of CK2K [4],
but curiously opposite functional e¡ects are observed
for small t antigen and CK2K on PP2A activity.
Now, we have tested the e¡ect on PP2A activity of
another protein, with a sequence related to the other
two proteins. This protein is CK2KP, the other cata-
lytic subunit of casein kinase 2 which is expressed
from a di¡erent gene to that of CK2K [6]. This pro-
tein has a region comprising residues 166^176, sim-
ilar to the region of small t antigen that interacts
with PP2A.
To test for the e¡ect of CK2KP on PP2A, we have
used the protein tau as a reporter. Tau protein is a
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microtubule-associated protein that in its hyperphos-
phorylated form is the main component of the paired
helical ¢laments found in the brains of Alzheimer’s
disease patients (see for example [7]). This phospho-
protein can be dephosphorylated by PP2A [8^12] in a
region present in the C-terminal half of the molecule.
Our results indicate that the expression of CK2KP
results in an increase in the phosphorylation level of
tau, suggesting that CK2KP decreases PP2A activity.
2. Experimental procedures
2.1. Materials
Lipofectin was from Gibco-BRL (Gaithersburg,
MD, USA). Antibody against tau protein, 7.51,
was a generous gift from Dr. C. Wischik (MRC,
Cambridge, UK) [13]. Antibody against catalytic
subunit KP of casein kinase 2 was a generous gift of
Dr. D.R. Marshak (Osiris Therapeutics, Baltimore,
MD, USA) [14]. Okadaic acid was from Sigma (St.
Louis, MO, USA). Protein phosphatase PP2A, cata-
lytic subunit, was obtained from Upstate Biotechnol-
ogy (Lake Placid, NY, USA). Casein kinase from rat
brain was a gift from Dr. F. Moreno (CBM, Madrid,
Spain).
The tau expression plasmids pSGT3RC,
pSGT4RC, PSGT2N and pSGT42, containing the
carboxy-terminal region of tau protein, the amino-
terminal region or the whole tau molecule have
been previously described [15,16]. Plasmid pSGT4RC
di¡ers from pSGT3RC in the presence of an addi-
tional tubulin-binding motif [7].
Defective SV40 virus, pSV NEOcasein kinase 2KP,
containing the cDNA of the casein kinase 2KP sub-
unit was kindly provided by Dr. A. Nieto (CNB,
Madrid, Spain). The defective virus was derived
from the construct described in [17] by inserting the
cDNA from CK2KP at the XbaI cleavage site. The
resulting construct did not express small t antigen (A.
Nieto, personal communication).
2.2. Cell culture, infection and transfection analysis
African green monkey kidney ¢broblast COS-1
cells [18] were grown in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 5% fetal bo-
vine serum. Infection of COS-1 cells with pSV40
NEOcasein kinase 2KP was performed by incubation
of the cultured cells with the defective virus at a
m.o.i. of 0.5^10 for 1 h at 37‡C, followed by the
removal of the virus-containing medium, washing
of the cell culture with fresh DMEM medium con-
taining 5% fetal bovine serum and further incubation
at 37‡C for 60 h. The cells were then collected, ho-
mogenized and the amount of protein in the cell ex-
tracts was determined. Transfection, using
pSGT3RC plasmid (containing the C-terminal region
of tau protein), was performed as previously indi-
cated [15,16] by adding 10 Wg of DNA and 20 Wg
of lipofectin (for one 60 mm dish) and the analyses
for the expressed proteins were done 60 h post trans-
fection. In some experiments COS-1 cells were in-
fected and transfected simultaneously.
In some cultures, okadaic acid (OA) was added to
serum-free medium at di¡erent concentrations (20
nM^1 WM) for 2 h. OA was added to the cells 60 h
post transfection and, after the treatment, the cells
were lysed and the level of tau phosphorylation was
tested.
Cell extracts were obtained by three freezing-thaw-
ing cycles in 0.1 M PIPES, pH 6.5, 0.5 mM MgCl2 ;
2 mM EGTA, 1 mM PMSF, 10 Wg/ml aprotinin; 10
Wg/ml leupeptin; 10 Wg/ml pepstatin.
Cell extracts from tau-transfected COS-1 cells were
treated with 0.5 units of PP2A for 30 min. The mix-
ture was incubated at 30‡C [8] and the level of tau
phosphorylation determined by gel electrophoresis
and Western blot using antibody (Ab) 7.51
[15,16,19].
2.3. Western blot
Ten Wg of uninfected or infected cell extracts were
fractionated by gel electrophoresis and blotted onto
nitrocellulose paper. Western blot was carried out
using anti-CK2KP or anti-tau and anti-rabbit or
anti-mouse peroxidase conjugated antibodies (Amer-
sham), according to the species of the primary anti-
bodies. Blots were developed by chemiluminescence
using the ECL Western blotting system (Amersham).
2.4. Phosphorylation of tau protein
Tau protein, and its amino- and carboxy-terminal
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fragments were phosphorylated with rat brain casein
kinase 2, isolated as indicated in [20]. The phospho-
rylation was carried out in 0.1 M MES, pH 6.4;
5 mM MgCl2 ; 10 Wg/ml polylysine; 1 mM PMSF;
0.5 units of kinase/mg substrate (activity determined
with casein) and 10 WM 32P-ATP, in a ¢nal volume
of 0.1 ml. The reaction was stopped by adding 0.1%
SDS (¢nal concentration) and the samples were char-
acterized by gel electrophoresis, followed by auto-
radiography (to localize the labelled peptide) and
counting the radioactivity associated to tau peptides
by Cerenkov radiation.
3. Results
3.1. Phosphorylation of tau by CK2
As a ¢rst step to study the e¡ect of CK2KP on
PP2A activity, using a fragment of protein tau in
phosphorylated form as substrate, we have analysed
whether that tau fragment can be modi¢ed by CK2,
because if that is the case it will interfere with the
phosphatase assay in that substrate.
In previous studies [20,21], it was observed that
phosphorylation of the whole tau molecule with
CK2 did not promote a signi¢cant electrophoretic
mobility shift of the protein (usually phosphorylation
dependent), but CK2 was able to modify tau protein
at its amino-half region. That result agrees well with
that shown in Fig. 1, showing that tau protein is
phosphorylated in vitro by CK2 (containing K and
KP subunits) at its amino-terminal region but not in
the tau fragments 3RC (or 4RC), that will be used as
substrates in phosphorylated form, to determinate
PP2A activity. Thus, the tau fragments containing
the C-terminal region can be used without additional
interferences.
3.2. Expression of CK2KP and tau protein upon
infection or transfection in COS-1 cells
The ¢rst step for our analysis was to test for any
endogenous expression of casein kinase 2KP subunit
in COS-1 cells. To do this, we used a speci¢c anti-
body for CK2KP subunit. Fig. 2A shows that the
antibody does not react with any protein in unin-
fected cells (Fig. 2Aa), whereas in pSVCK2KP-in-
fected cells it reacts with a protein with the electro-
phoretic mobility of the CK2KP subunit (Fig. 2Ab).
Additionally, we observed no reaction of cellular
proteins in control cell extracts with the tau antibody
7.51 (Fig. 2Ba), whereas upon transfection with plas-
mid pSGT3RC, expressing the C-terminal region of
tau protein, two immunoreactive peptides are de-
Fig. 1. Phosphorylation of tau by casein kinase 2. (Top) The
scheme shows the longest tau isoform t42 (containing exons 2,
3 and 10), the fragment containing the amino-terminal region
(2N) and that containing the carboxy-terminal region (4RC)
(Bottom). The proteins shown in the top part were phosphoryl-
ated in vitro by CK2 under the conditions indicated in Section
2. The result, average of three experiments, is shown.
Fig. 2. Western blot analysis of CK2KP and tau overexpression
in COS-1 cells. (A) Extracts from COS-1 cells, untreated (lane
a) or infected (lane c) with pSV NEOcasein kinase 2KP vector,
were analysed by Western blot using an antibody against the
CK2KP subunit. Cells in lane c were also transfected with tau
3RC cDNA. (B) Twenty Wg of extracts from COS-1 cells un-
treated (lane a) or transfected (lane c) with tau 3RC cDNA
(see [13]) were analysed by Western blot using 7.51, an anti-
body against tau. Cells in lane c were also infected with pSV
NEOcasein kinase 2KP vector. Molecular mass markers run in
parallel in both blots A and B are indicated.
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tected (Fig. 2Bb). These two polypeptides correspond
to the tau carboxy-terminal fragment in phosphoryl-
ated (slower electrophoretic mobility) or unphos-
phorylated (faster electrophoretic mobility) forms,
as has been previously indicated [15,16,19].
In cells simultaneously infected and transfected,
both proteins, CK2KP and the tau fragment, were
expressed (Fig. 2Ac,Bc).
3.3. Dephosphorylation of the tau fragment is
prevented by okadaic acid and promoted by PP2A
COS-1 cells, transfected with the plasmid express-
ing the C-terminal region of tau protein, were un-
treated (Fig. 3a) or treated with okadaic acid (an
inhibitor of PP2A) and the proportion of the slower
(phosphorylated) and faster (unphosphorylated) tau
fragments was characterized by gel electrophoresis
and Western blot. Fig. 3c shows that in the presence
of okadaic acid there is an increase in the proportion
of the phosphorylated peptide. This result suggests
that phosphotau is dephosphorylated by PP2A. Con-
sistent with this, an increase in the unphosphorylated
tau fragment was observed when an extract from
tau-transfected cells was incubated with partially pu-
ri¢ed PP2A (Fig. 3b).
The previous results are compatible with a possible
role of PP2A in dephosphorylating phospho 3RC tau
fragment, since a PP2A drug inhibitor (okadaic acid)
prevents that phosphorylation. However, the drug
concentration used was so high that other phospha-
tases could also be inhibited in these conditions, like
PP1. To test whether PP2A is indeed the phospha-
tase mainly involved in the dephosphorylation of tau
fragment, COS-1 cells (expressing tau fragment and
CK2KP) were treated in the absence (Fig. 4a,d) or the
presence (Fig. 4b 20 nM, Fig. 4c 100 nM) of OA. At
the lower drug concentration mainly PP2A was in-
hibited, and, as shown in Fig. 4b, the dephosphoryl-
ation of tau is also inhibited. Moreover, when a cell
extract of these treated cells was incubated in vitro,
in the presence of 20 nM OA, tau dephosphorylation
was again prevented (not shown), whereas in the
absence of drug, tau fragment is dephosphorylated
by adding phosphatase PP2A (Fig. 4d).
3.4. Expression of CK2KP results in an increase in
phosphorylated tau in COS-1 cells
Tau is a phosphoprotein in which the unmodi¢ed
and modi¢ed forms can be identi¢ed based on their
di¡erent electrophoretic mobilities [19]. This feature
can be observed more easily using a small carboxy-
terminal fragment of tau [16]. In this case two poly-
peptides, corresponding to the phosphorylated and
Fig. 3. Western blot analysis of the e¡ect of okadaic acid on
tau dephosphorylation. Extracts from COS-1 cells transfected
with tau 3RC cDNA (a and b) and additionally treated with
1 WM okadaic acid (c) were analysed by Western blot using
7.51, an antibody against tau. In (b) the extract was further in-
cubated with phosphatase. Phosphorylated (slowly migrating)
and unphosphorylated (fast migrating) forms of tau can be ob-
served in the blot. Molecular mass markers run in parallel are
indicated.
Fig. 4. E¡ect of okadaic acid on tau fragment dephosphoryla-
tion. Untreated (a,d) or OA treated (20 nM, b; 100 nM, c) tau
transfected COS-1 cells were homogenized, fractionated by gel
electrophoresis, blotted and incubated with Ab 7.51. In (d), a
cell extract protein from (a) was incubated with PP2A, as indi-
cated in Section 2.
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non-phosphorylated fragments, with di¡erent elec-
trophoretic mobilities can be observed [15,16]. Pre-
vious work has indicated that phosphorylated tau
can be dephosphorylated by PP2A [8^11,22] (see
also above), and by coexpressing the protein with
SV40 small t antigen. It has also been shown that
PP2A regulates the phosphorylation state of tau [12].
By following a similar approach we have tested the
role of CK2KP in phosphotau dephosphorylation by
coexpression of tau and CK2KP in COS-1 cells.
Fig. 5a^c shows that in extracts from tau-trans-
fected COS-1 cells, tau antibody Ab 7.51 reacts
with the two peptides corresponding to the modi¢ed
(slow migrating peptide) and unmodi¢ed (fast mi-
grating peptide) fragments.
As shown in Fig. 5c, an increased expression of
CK2KP results in an increase in the proportion of
phosphorylated tau fragment, a polypeptide that is
not modi¢ed by CK2 [20,21] (see also Fig. 1), but is
dephosphorylated by PP2A. Although the plasmid
expressing CK2KP is not expressing SV40 small t
antigen [17], a control with defective SV40 virus lack-
ing the cDNA for CK2KP was, in any case, per-
formed. Fig. 5a shows that when the same m.o.i.
(as that used in Fig. 5c) was used for the virus lack-
ing the cDNA for CK2K, a lower e¡ect on tau de-
phosphorylation than that for the virus expressing
CK2KP was observed (compare Fig. 5a and c). This
result suggests that CK2KP could slightly modulate
the action of PP2A on tau fragment dephosphoryla-
tion. The previous results were also con¢rmed by
doing a dose dependent experiment in which the
amount of tau fragment (in phosphorylated form)
was measured versus increasing amounts of express-
ing CK2KP. Fig. 6 indicates an increase in the phos-
phorylated form that correlates with an increase in
CK2KP expression. This expression was tested by
Western blot using an antibody raised against
CK2KP [14] and it was observed (data not shown)
that, at higher m.o.i. (using an SV40 defective virus
expressing CK2KP), a higher amount of CK2KP was
found.
Fig. 5. Western blot analysis of the e¡ect of okadaic acid on
tau dephosphorylation. (a^c) Protein extracts from COS-1 cells
transfected with tau 3RC. Protein from uninfected cells (b), in-
fected with pSV NEOcasein kinase 2KP vector (c), or with pSV,
without CK2KP cDNA insert, at m.o.i. of 25 (a), were analysed
by Western blot using Ab 7.51, an antibody against tau. The
proportion of phosphorylated or unphosphorylated tau frag-
ment is indicated by looking at the two peptides with di¡erent
electrophoretic mobilities.
Fig. 6. Increase in the level of phosphorylated tau fragment de-
pending on CK2KP expression. Tau transfected COS-1 cells
were infected with SV40 defective virus, expressing CK2KP, at
di¡erent m.o.i. : 0 (a), 2 (b), 10 (c) and 25 (d). After cell ho-
mogenization, tau protein fragment was characterized by gel
electrophoresis and Western blotting using Ab 7.51. Two pro-
teins in each case are stained, corresponding to the phosphoryl-
ated and unphosphorylated tau fragments. The reaction of the
antibody proteins with both was quanti¢ed by densitometry
and the percentage of phosphorylated peptide with respect to
both peptides is shown.
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4. Discussion
Protein phosphatase 2A (PP2A) contains a regula-
tory B subunit that may be exchanged with other
proteins such as SV40 small t antigen [3] or the
CK2K subunit [4]. This exchange may occur through
the binding of these proteins to the phosphatase core
enzyme composed of A and C subunits [23]. In this
binding the sequences indicated in Table 1 could be
involved. Despite the similarity between the two se-
quences, the e¡ects of small t antigen and CK2K on
PP2A activity are opposites. The presence of small t
antigen decreases phosphatase activity whereas the
activity of the enzyme increases in the presence of
CK2K. CK2K is one of the two isoforms of the cata-
lytic subunit of casein kinase 2, the other being the
KP isoform [24]. The two isoforms are expressed from
di¡erent genes and their expression is regulated dif-
ferently in some cells [24,25]. The sequence of the KP
subunit shows a great similarity to that of the K
subunit. However, in the region comprising the pu-
tative binding site for PP2A core enzyme there are
some di¡erences between the CK2K and CK2KP sub-
units (Table 1). In the present work we have tested
whether CK2KP modi¢es PP2A activity like it does
for small t antigen (decreasing the activity) or for
CK2K (increasing the activity). Our experimental
model has been COS-1 cells.
We found that the expression of CK2KP results in
a decrease of phosphatase activity. This indicates a
functional di¡erence between CK2K and CK2KP cat-
alytic subunits, which may be due to structural di¡er-
ences in their PP2A binding region. Indeed CK2K
binds to PP2A in a direct way [4], increasing PP2A
activity, whereas in a direct or indirect way, CK2KP
has the opposite e¡ect on PP2A.
In Table 1, we have compared the three sequences
(from small t antigen, CK2K and CK2KP) to try to
look for a possible correlation between sequence and
function. Since a similar function was observed for
CK2KP and small t antigen, we looked for residues
conserved between these two proteins which are not
conserved in CK2K. Interestingly, within the con-
served block common to all three proteins, a single
amino acid was found to ¢t these criteria (Table 1).
In CK2KP and small t antigen this residue is Q and
N, respectively, whereas in CK2K, this position is
occupied by H. We speculated that the amido group
of glutamine or asparagine could play a role in de-
creasing the phosphatase activity promoted by
CK2KP and small t antigen.
The functional di¡erences between CK2K and
CK2KP may explain some previous observations on
the behaviour of PP2A substrates. An example is the
preferential distribution of phosphoMAP1B and
phosphotau (not dependent on casein kinase 2 phos-
phorylation) in the dendrites of neurones [26^29]. It
has been described that both phosphotau and phos-
phoMAP1B may be dephosphorylated by PP2A [8^
10], and that there is a preferential accumulation of
these phosphoisoforms in dendrites [26^29]. This ob-
servation can now be explained based on the results
of the present work together with the recent ¢nding
that there is a speci¢c localization of CK2KP in den-
drites [30], whereas CK2K is present in other neurone
regions like the axon, in which MAP1B and tau are
in unphosphorylated form [26^29].
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Table 1
Sequence comparison of CK2K, CK2K’ and SV40 t antigen
Region of similarity observed among the di¡erent sequences.
The di¡erent amino acids within the conserved block are under-
lined. The residues of the sequences are numbered for each pro-
tein and the identical amino acids present in the three sequences
are indicated by vertical lines.
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